Nalgesin S (Naproxen Sodium)

Naproxen sodium blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for producing prostaglandins. By lowering prostaglandin levels, it diminishes inflammation, reduces pain signaling, and helps bring down elevated body temperature.

The appropriate dose of Nalgesin S is determined by a qualified prescriber based on the individual’s medical condition, age, weight, and response to therapy. Patients should follow the dosing instructions provided by their healthcare professional.

Safety of naproxen sodium in pregnancy or while nursing has not been fully established. It is generally advised to avoid NSAIDs, especially in the third trimester, unless the benefits outweigh the risks. Pregnant or breastfeeding individuals should discuss alternatives with their doctor.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both naproxen sodium and ibuprofen belong to the NSAID class and share similar mechanisms of COX inhibition. Naproxen generally has a longer half‑life, allowing less frequent dosing, while ibuprofen may have a quicker onset. Choice between them depends on clinical judgment, patient tolerance, and specific therapeutic goals.

Nalgesin S should be stored at room temperature, below 25 °C. Keep the tablets in their original packaging, protect them from moisture, heat and direct sunlight to maintain potency throughout the shelf life.

Nalgesin S is taken orally, usually with a full glass of water. For optimal gastrointestinal tolerance, it can be taken with food or an antacid, unless otherwise directed by the prescribing clinician.

Serious risks include gastrointestinal bleeding or ulceration, severe cardiovascular events such as heart attack or stroke, renal impairment, and rare but severe skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice signs of bleeding, chest pain, sudden kidney problems, or skin rash.

Individuals with a known allergy to naproxen or any NSAID, those with active gastrointestinal ulcers, severe heart failure, uncontrolled hypertension, or significant renal or hepatic impairment should avoid using Nalgesin S. A healthcare professional should evaluate suitability before prescribing.